Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 29, 2017 - Issue 3
49
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Response to Goldberg and Burnett (2016, IT)

&
Pages 93-95 | Received 30 Dec 2016, Accepted 21 Feb 2017, Published online: 19 Mar 2017

References

  • Clark PK. (1987). The cyclical component of economic activity. Q J Econ 102:797–814.
  • Goldberg MS, Burnett RT. (2016). Re: “a new time-series methodology for estimating relationships between elderly frailty, remaining life expectancy, and ambient air quality”. Inhal Toxicol 28:481–3.
  • Hamilton JD. (1994). Time series analysis. Princeton University Press.
  • Harvey AC. (1989). Forecasting. Structural time series models and the Kalman filter. Cambridge University Press.
  • Harvey AC. (1983). Time series models. MIT Press.
  • Klemm RJ, Lipfert FW, Wyzga RE, Gust C. (2004). Daily mortality and air pollution in Atlanta: Two years of data from ARIES. Inhal Toxicol 16:131–41.
  • Knudsen SJ. (2001). A frail population state-space model for mortality with application to air pollution data for Toronto, Canada. in New Trends in Statistical Modelling, proc 16th International Workshop on Statistical Modelling, Odense, Denmark. 167–197.
  • Murray CJ, Nelson CR. (2000). State-space modeling of the relationship between air quality and mortality. J Air Waste Manag Assoc 50:1075–80.
  • Murray CJ, Lipfert FW. (2010). Revisiting a population-dynamic model of air pollution and daily mortality of the elderly in Philadelphia. J Air Waste Manag Assoc 60:611–28.
  • Murray CJ, Lipfert FW. (2012). A new time-series methodology for estimating relationships between elderly frailty, remaining life expectancy, and ambient air quality. Inhal Toxicol 24:89–98.
  • Murray CJ, Lipfert FW. (2013). Inferring frail life expectancies in Chicago from daily fluctuations in elderly mortality. Inhal Toxicol 25:461–79.
  • Smith RL, Davis JM, Speckman P. (1999). Assessing the human health risk of atmospheric particles. Novartis Found Symp 220:59–72.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.